2024
|
Invention
|
Tyk2 pseudokinase ligands and uses thereof. Described herein are compounds that are useful in the... |
|
Invention
|
Pharmaceutical composition of trametinib and process of preparation thereof. The present subject ... |
2023
|
Invention
|
Tyk2 pseudokinase ligands and uses thereof. Described herein are compounds of formula (I) that ar... |
|
Invention
|
Gold nanoconjugates. The present disclosure provided compounds, nanoconjugates, and compositions ... |
|
Invention
|
Pharmaceutical composition containing combination of azilsartan and chlorthalidone and process of... |
2022
|
Invention
|
Pharmaceutical composition containing combination of meloxicam and rizatriptan and process of pre... |
|
Invention
|
Continuous process for preparation of pregabalin. The present invention relates to a continuous p... |
|
P/S
|
Providing information relating to diagnostic, prophylactic and therapeutic properties of pharmace... |
|
Invention
|
Pharmaceutical composition of ivosidenib. Present disclosure is directed to solid pharmaceutical ... |
2021
|
Invention
|
Bioavailable oral dosage form of tyrosine-kinase inhibitor.
A pharmaceutically acceptable compos... |
|
Invention
|
A solid dispersion of ponatinib hydrochloride and process of preparation thereof. The present sub... |
|
Invention
|
Pharmaceutical composition of lasmiditan and process of preparation thereof. The present subject ... |
|
Invention
|
Solid state forms of venetoclax and its process for the preparation there of. The present inventi... |
2020
|
Invention
|
An improved process of preparation of ivosidenib.
The present invention relates to an improved p... |
|
Invention
|
An improved process of preparation of ivosidenib. The present invention relates to an improved pr... |
|
Invention
|
Pharmaceutical composition comprising venetoclax.
The present subject matter provides amorphous ... |
|
Invention
|
Pharmaceutical composition comprising venetoclax. The present subject matter provides amorphous s... |
|
Invention
|
Process of preparation of benzimidazole compounds. The application provides process of preparatio... |
|
Invention
|
Stable liquid composition of cyclophosphamide. The present subject matter relates to a ready-to-u... |
2019
|
Invention
|
Pharmaceutical composition of axitinib. The present subject matter is directed to a stable pharma... |
|
Invention
|
Pharmaceutical composition of osimertinib. The present invention relates to pharmaceutical compos... |
2018
|
Invention
|
Process for the characterization of glatiramer acetate.
The present invention is directed to pro... |
|
Invention
|
Process for the characterization of glatiramer acetate. The present invention is directed to proc... |
|
Invention
|
An improved process for preparation of obeticholic acid. The invention relates to an improved pro... |
2017
|
Invention
|
Stable pharmaceutical composition comprising telmisartan and amlodipine besylate. The invention r... |
|
Invention
|
Process for the preparation of brexpiprazole and intermediates thereof. The present invention rel... |
|
Invention
|
Process for the preparation of (sp)-sofosbuvir and intermediates thereof. The present invention i... |
|
Invention
|
Novel salts and polymorphic forms of panobinostat. The present invention provides novel crystalli... |
|
Invention
|
Process for the preparation of olaparib and polymorphs thereof. The present invention is directed... |
2016
|
Invention
|
Polymorph of riociguat and its process for the preparation. The present invention relates to nove... |
|
Invention
|
Novel polymorph of riociguat and its process for the preparation. The present invention relates t... |
|
Invention
|
Stable pharmaceutical composition of alogliptin and metformin fixed dose combination.
The presen... |
|
Invention
|
Stable pharmaceutical composition of alogliptin and metformin fixed dose combination. The present... |
|
Invention
|
Process and novel polymorphic form of apremilast. The present invention provides an improved proc... |
|
Invention
|
An improved process and novel polymorphic form of apremilast. The present invention provides an i... |
2015
|
Invention
|
Polymorphic forms of vortioxetine and its pharmaceutically acceptable salts. The present inventio... |
|
Invention
|
Novel polymorphic forms of vortioxetine and its pharmaceutically acceptable salts. The present in... |
|
Invention
|
Process for the preparation of vilazodone hydrochloride and its amorphous form. The present inven... |
2014
|
Invention
|
An improved process for the preparation of dasatinib. The present invention relates to a novel sy... |
|
Invention
|
Stable pharmaceutical composition of asenapine. The present invention relates to a stable pharmac... |
|
Invention
|
An improved process for the preparation of teriflunomide. The present invention provides an impro... |
2013
|
Invention
|
An improved process for preparation of minodronic acid. The present invention relates to an impro... |
|
Invention
|
A novel process for the preparation of silodosin. The present invention relates to a novel proces... |
|
Invention
|
Process for the synthesis of apixaban. The present invention relates to the Process for the prepa... |
|
Invention
|
Tadalafil tablet composition with reduced dose strength. The Present invention contemplates a pha... |
|
Invention
|
Reference markers for fesoterodine fumarate. The present invention relates to the new impurities ... |
|
Invention
|
Process for the preparation of fesoterodine.
The present invention relates to an improved proces... |